Has there ever been so many clickbait keywords in a single scientific breakthrough? Researchers in Swedish researcher have ...
We gave you a run-down on majors like BHP and Rio Tinto yesterday. Here's how another 7 miners are shaping up before they ...
Paradigm Pharmaceuticals (ASX:PAR) has identified the potential of PPS, an FDA-approved drug to treat osteoarthritis.
Good morning, and Happy Thursday to you all! Here’s everything you need (and some stuff you don’t need) to know before the ...
Stockhead’s Sarah Hughan sits down with Frontier Energy (ASX:FHE) CEO Adam Kiley to get the short end of the long story on ...
Silver-focused Sun Silver is looking to raise up to $13m through an IPO priced at 20c per share Its Maverick Springs project ...
Less homes, more buyers is the grim takeout from PropTrack’s latest analysis of property listings from around the country.
Evolution says it can pull off a miracle June quarter and hit an ambitous FY24 gold target. But record prices could salvage ...
Alpha HPA and Renascor receive a sugar daddy hug from Albo this week. Lithium's "spot" pricing trends… steadily. So that's ...
Neurotech International (ASX:NTI) reports positive outcomes from its Phase 2/3 NTIASD2 clinical trial targeting children ...
Want to know how the big ASX miners were expected to perform in the March quarter reporting season? Follow our guide here.
Maronan has announced promising metallurgical results from its namesake silver-lead and copper-gold deposit in Northwest ...